The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
By Matthew J. Page, J. McKenzie, Patrick M. M. Bossuyt, I. Boutron, Tammy Hoffmann, C. Mulrow, Larissa Shamseer, J. Tetzlaff, Elie A. Akl, S. Brennan and 16 more. British medical journal, 2020
94,440 citations recorded by the source corpus.
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.
Subfields: Epidemiology, Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/f4de50b3dc5d1d850d281ef0cfefb80be2af34f2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Sociology and Political Science
In Statistics and Probability
- Matthew J. Page
- David Moher
- Julie May Glanville
- Andrea C. Tricco
- M. Rethlefsen
- S. Waffenschmidt
- S. Kirtley
- Jonathan B. Koffel
Citations in the corpus
- Artificial Intelligence for Student Assessment: A Systematic Review (2021, methodology): “Specifically, the PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) will be used as a model for this review [33].”
- Artificial intelligence in intelligent tutoring systems toward sustainable education: a systematic review (2023, methodology): “The overall paper selection and screening process is illustrated in the following figure, which follows the PRISMA paper selection process from identification, screening, and eligibility.”
- Remote patient monitoring using artificial intelligence: Current state, applications, and challenges (2023, methodology): “In FIGURE 2 Study flow diagram PRISMA-ScR (Page et al., 2021) their study, Snoswell et al. (2021) reviewed 38 meta-analysis articles published between 2010 and 2019 and covered 10 medical disciplines including multidisciplinary care and other specialized disciplines like cardiovascular disease and…”
- PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews (2021, positive): “Discussion and conclusions The PRISMA-S extension is designed to be used in conjunction with PRISMA 2020 [35] and PRISMA extensions including PRISMA-P for protocols [36], PRISMAScR for scoping reviews [139], the PRISMA Network Meta-analyses statement [140], and PRISMA-IPD for systematic reviews usin”
- Opportunities and Challenges for ChatGPT and Large Language Models in Biomedicine and Health (2023, background): “Therefore, it is imperative to arrive at a reporting consensus, such as the PRISMA statement [137] for systematic reviews, for evaluating biomedical LLMs. Alternatively, there are two main approaches to evaluate LLM answers without involving expert evaluators.”
- Best practice guidance and reporting items for the development of scoping review protocols (2022, positive): “The authors may choose to detail the planned use of an adapted PRISMA 2020 flow diagram 29 or the METHODOLOGY M.D.J. Peters et al. adapted chart in the PRISMA-ScR 5 to graphically depict the movement of sources through the search process to eventual inclusion.”
- Practical and ethical challenges of large language models in education: A systematic scoping review (2023, methodology): “We followed the PRISMA (Page et al., 2021) protocol to conduct the current systematic scoping review of LLMs.”
- CONSORT 2025 statement: updated guideline for reporting randomised trials (2025, neutral): “32 The expanded checklist comprises an abridged version of elements presented in the CONSORT 2025 explanation and elaboration document, 29 with examples and references removed (appendix p 5).”